207 related articles for article (PubMed ID: 24535126)
1. Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study.
Bilmon IA; Ashton LJ; Le Marsney RE; Dodds AJ; O'Brien TA; Wilcox L; Nivison-Smith I; Daniels B; Vajdic CM;
Bone Marrow Transplant; 2014 May; 49(5):691-8. PubMed ID: 24535126
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.
Yamasaki S; Suzuki R; Hatano K; Fukushima K; Iida H; Morishima S; Suehiro Y; Fukuda T; Uchida N; Uchiyama H; Ikeda H; Yokota A; Tsukasaki K; Yamaguchi H; Kuroda J; Nakamae H; Adachi Y; Matsuoka KI; Nakamura Y; Atsuta Y; Suzumiya J
Bone Marrow Transplant; 2017 Jul; 52(7):969-976. PubMed ID: 28368379
[TBL] [Abstract][Full Text] [Related]
3. Second malignancies after autologous hematopoietic cell transplantation in children.
Danner-Koptik KE; Majhail NS; Brazauskas R; Wang Z; Buchbinder D; Cahn JY; Dilley KJ; Frangoul HA; Gross TG; Hale GA; Hayashi RJ; Hijiya N; Kamble RT; Lazarus HM; Marks DI; Reddy V; Savani BN; Warwick AB; Wingard JR; Wood WA; Sorror ML; Jacobsohn DA
Bone Marrow Transplant; 2013 Mar; 48(3):363-8. PubMed ID: 22964594
[TBL] [Abstract][Full Text] [Related]
4. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
5. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
[TBL] [Abstract][Full Text] [Related]
7. Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study.
Vajdic CM; Mayson E; Dodds AJ; O'Brien T; Wilcox L; Nivison-Smith I; Le Marsney R; Daniels B; Ashton LJ;
Biol Blood Marrow Transplant; 2016 May; 22(5):949-56. PubMed ID: 26860637
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.
Ong DM; Farrugia H; Wei A
Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346
[TBL] [Abstract][Full Text] [Related]
9. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
10. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).
Mailankody S; Pfeiffer RM; Kristinsson SY; Korde N; Bjorkholm M; Goldin LR; Turesson I; Landgren O
Blood; 2011 Oct; 118(15):4086-92. PubMed ID: 21795746
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
12. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors.
Baker KS; DeFor TE; Burns LJ; Ramsay NK; Neglia JP; Robison LL
J Clin Oncol; 2003 Apr; 21(7):1352-8. PubMed ID: 12663726
[TBL] [Abstract][Full Text] [Related]
13. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
14. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
Forrest DL; Hogge DE; Nevill TJ; Nantel SH; Barnett MJ; Shepherd JD; Sutherland HJ; Toze CL; Smith CA; Lavoie JC; Song KW; Voss NJ; Gascoyne RD; Connors JM
J Clin Oncol; 2005 Nov; 23(31):7994-8002. PubMed ID: 16204014
[TBL] [Abstract][Full Text] [Related]
15. A population-based cohort study of late mortality in adult autologous hematopoietic stem cell transplant recipients in Australia.
Ashton LJ; Le Marsney RE; Dodds AJ; Nivison-Smith I; Wilcox L; O'Brien TA; Vajdic CM
Biol Blood Marrow Transplant; 2014 Jul; 20(7):937-45. PubMed ID: 24631736
[TBL] [Abstract][Full Text] [Related]
16. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
[TBL] [Abstract][Full Text] [Related]
17. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study.
Frisch M; Hjalgrim H; Olsen JH; Melbye M
Ann Intern Med; 1996 Nov; 125(10):815-21. PubMed ID: 8928988
[TBL] [Abstract][Full Text] [Related]
18. Therapy-related myelodysplasia and acute myeloid leukemia.
Bhatia S
Semin Oncol; 2013 Dec; 40(6):666-75. PubMed ID: 24331189
[TBL] [Abstract][Full Text] [Related]
19. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients.
Crocetti E; Carli P
Eur J Cancer Prev; 2004 Feb; 13(1):33-7. PubMed ID: 15075786
[TBL] [Abstract][Full Text] [Related]
20. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
